The goal of this study is the development of a clinically verified functional imaging technique of the retina.
ID
Source
Brief title
Condition
- Eye disorders congenital
- Congenital eye disorders (excl glaucoma)
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Identification and classification of optical features that indicate the
functionality of the retina in healthy individuals and in patients with retinal
dystrophies.
Secondary outcome
Not applicable.
Background summary
Retinal dystrophies represent a group of inherited ophthalmic diseases, which
are characterized by progressive dysfunction or loss of retinal photoreceptor
cells, often accompanied by fundus abnormalities. Retinal dystrophies represent
the most important cause of juvenile blindness in the Western world for which
no treatment is currently available. Although gene-therapy treatments for
retinal dystrophies are currently being developed, clinical characterization of
these diseases is largely based on assessments with a strong subjective
component, poor sensitivity, and poor resolution. Therefore there is a growing
demand to improve current examination techniques, in order to find out which
patients may be amenable for such treatments. Recent advances in retinal
imaging techniques have increased the abilities of clinical characterization,
including the accurate monitoring of disease progression and detection of
remaining functional retina in retinal dystrophies. While currently available
devices only allow for morphological retinal imaging, imaging of photoreceptor
function has been shown to be feasible in several studies. This innovative
functional retinal imaging provides the opportunity to observe retinal function
on a micrometer scale, which will be of great significance for patient
selection for, and documentation of future gene-therapeutic studies.
Study objective
The goal of this study is the development of a clinically verified functional
imaging technique of the retina.
Study design
Prospective case-control study.
Study burden and risks
Participants do not benefit at the time of the study. All procedures are
non-invasive and there are no significant risks known about the examination
techniques applied in our study. The additional time spent for study
investigations will be about one hour.
Philips van Leydenlaan 15
Nijmegen 6500 HB
NL
Philips van Leydenlaan 15
Nijmegen 6500 HB
NL
Listed location countries
Age
Inclusion criteria
-Patients recruited from the RP5000 study (see Onderzoeksprotocol, page 7 + 8) with one of the following non-syndromic retinal dystrophies: Retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease or cone-rod dystrophy.
-Healthy independent volunteers with normal retinal functionality.
-All study participants are of mature age and of sound mind and judgement.
-Both eyes are able to fixate adequately for the imaging procedure.
-Absence of cataract in both eyes.
Exclusion criteria
Healthy volunteers and patients, who do not meet the inclusion criteria.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL40790.091.12 |